Amphora Discovery and CHDI, Inc. have signed multiple agreements that provide CHDI access to Amphora Discovery’s integrated contract discovery services. CHDI is seeking an approach to rapidly discover and develop drugs that prevent or slow Huntington Disease (HD), an inherited degenerative brain disease for which there is no treatment to delay or prevent its onset. The agreements cover multiple biological targets implicated in HD and include access to Amphora Discovery’s Precisi...